ResMed Inc. (RMD) has a consensus analyst rating of Buy, based on 35 analysts covering the stock. Of those, 16 recommend buying, 14 recommend holding, and 5 recommend selling.
The analyst consensus price target for RMD is $295.88, representing a +28.3% upside from the current price of $230.69. Price targets range from a low of $265.00 to a high of $345.00.
